Published in Curr Heart Fail Rep on September 22, 2017
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (2001) 12.98
Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58
Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med (2008) 9.62
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med (2004) 7.80
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A (2001) 6.76
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell (2010) 5.23
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet (2001) 5.18
Fiber types in mammalian skeletal muscles. Physiol Rev (2011) 4.63
The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J (2006) 4.10
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation (1992) 3.27
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem (2002) 3.07
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J (2011) 2.97
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J (2012) 2.60
Alterations of skeletal muscle in chronic heart failure. Circulation (1992) 2.58
Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta (2008) 2.56
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
Mechanisms regulating skeletal muscle growth and atrophy. FEBS J (2013) 2.40
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol (2003) 2.35
Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail (2014) 2.30
Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res (2005) 2.12
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation (1996) 2.10
Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation (1990) 2.06
Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res (2001) 1.88
Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol (2013) 1.73
Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med (2002) 1.72
Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail (2011) 1.69
Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J (2007) 1.65
Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation (1989) 1.64
Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. Circulation (1985) 1.63
The ubiquitin-proteasome system and skeletal muscle wasting. Essays Biochem (2005) 1.49
Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation (1986) 1.46
The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta (2008) 1.43
Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol (2014) 1.43
Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J (2004) 1.43
Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J Gerontol A Biol Sci Med Sci (2013) 1.27
Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care (2013) 1.27
Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle. Mech Ageing Dev (2006) 1.25
Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol (2002) 1.22
TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab (2002) 1.22
Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res (2001) 1.21
Animal models of heart failure with preserved ejection fraction. Neth Heart J (2016) 1.19
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol (1998) 1.19
Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol (2014) 1.19
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility. Cardiovasc Res (2006) 1.16
A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. Circ Heart Fail (2010) 1.15
Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol (1997) 1.15
Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation (2000) 1.14
Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. Eur J Heart Fail (2009) 1.14
Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure. Am J Physiol Heart Circ Physiol (2006) 1.14
Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol (2001) 1.12
Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I. Am J Physiol Regul Integr Comp Physiol (2006) 1.10
Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle (2015) 1.05
Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Basic Res Cardiol (2003) 1.04
Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. Eur J Heart Fail (2015) 1.03
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cell Mol Life Sci (2014) 1.03
Mitochondrial dysfunction in heart failure. Heart Fail Rev (2013) 1.02
Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. Am J Cardiol (1983) 0.99
Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine (2009) 0.99
Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes. PLoS One (2015) 0.97
Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training. Eur J Cardiovasc Prev Rehabil (2008) 0.96
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail (2012) 0.95
Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med (2010) 0.95
Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation (1990) 0.94
Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol (2011) 0.93
Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation (1997) 0.92
Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol (1999) 0.92
Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia. Cancer Res (1999) 0.91
Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch (2006) 0.90
Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int Immunopharmacol (2009) 0.90
Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks. Crit Rev Clin Lab Sci (2011) 0.90
Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc Res (1999) 0.90
Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure. J Appl Physiol (1985) (1997) 0.90
Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J Card Fail (2004) 0.88
Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance. JACC Heart Fail (2016) 0.87
Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure. J Card Fail (2014) 0.87
Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization. Am J Physiol Heart Circ Physiol (2015) 0.87
Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm. J Cachexia Sarcopenia Muscle (2015) 0.87
Congestive heart failure: differential adaptation of the diaphragm and latissimus dorsi. J Appl Physiol (1985) (1995) 0.83
Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study. Circ Heart Fail (2013) 0.83
Chronic Heart Failure and Inflammation: What Do We Really Know? Circ Res (2016) 0.82
Skeletal muscle fiber composition and capillarization in patients with chronic heart failure: relation to exercise capacity and central hemodynamics. J Card Fail (1995) 0.82
Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity. J Mol Cell Cardiol (2011) 0.82
Wnt/β-Catenin Signaling Contributes to Skeletal Myopathy in Heart Failure via Direct Interaction With Forkhead Box O. Circ Heart Fail (2015) 0.80
Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure. Circ Heart Fail (2017) 0.80
Heart failure and cachexia: insights offered from molecular biology. Front Biosci (2008) 0.78
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction. Circulation (2017) 0.77
Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure. J Cell Physiol (2015) 0.77
How Do Skeletal Muscles Die? An Overview. Adv Exp Med Biol (2015) 0.76
Exercise Training for Prevention and Treatment of Heart Failure. Prog Cardiovasc Dis (2017) 0.76